The Dawn of a New Pharmaceutical Epoch: Can AI and Robotics Reshape Drug Formulation?
Where this comes from
- Record sourced from PubMed, PMID 39155417.
- Also identified by DOI 10.1002/adhm.202401312 and PMC identifier 11582498.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Over the last four decades, pharmaceutical companies' expenditures on research and development have increased 51-fold. During this same time, clinical success rates for new drugs have remained unchanged at about 10 percent, predominantly due to lack of efficacy and/or safety concerns. This persistent problem underscores the need to innovate across the entire drug development process, particularly in drug formulation, which is often deprioritized and under-resourced.
Medical subject headings
- Artificial Intelligence
- Drug Compounding
- Robotics